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1. Introduction
   India has several traditional medical systems, such as 
Ayurveda and Unani, which have survived more than 3 000 
years, mainly using plant-based drugs. There are many 
hepatoprotective, antiulcer, antioxidants, gastro protective 
plants known from the wealth of traditional Ayurveda and 
folklore medicines but their introduction into modern therapy 
awaits scientific validation. Scientific research in herbal 
medicine with hepatoprotective and antioxidant activity may 
be of great benefit as an alternative therapy for different liver 
diseases. The exposure to drugs, food additives, dangerous 
chemicals etc. and their metabolic products makes the 
liver unstable such as acute or chronic inflammations like 
hepatitis, cirrhosis etc.  
   Free radicals are highly reactive molecules or chemical 
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species capable of independent existence which plays an 
important role in a number of biological processes such as 
intracellular killing bacteria by phagocytic cells (granulocytes 
and macrophages), and also implicated in certain cell 
signalling processes[1]. Their production however, multiplies 
several folds during pathological conditions, which results in 
many diseases such as atherogenesis, parkinson’s disease, 
liver diseases, diabetes etc. Antioxidants play a key role 
in these defense mechanisms by removing free radical 
intermediates, and inhibiting other oxidation reactions, thus 
preventing oxidative stress[2]. Hence the rationale for the 
use of antioxidants is well established in prevention and 
treatment of diseases where oxidative stress plays a major 
aetiopathological role[3]. In this aspect, natural antioxidant 
products got attention for their scientific validation and 
clinical use.
   Cyclea peltata (Poir.) Hook. f. & Thoms. (C. peltata) 
(Menispermaceae) is locally called Padathaali  or 
Padakkizhangu. It is a much branched climbing shrub found 
throughout South and East India with tuberous roots, peltate 
leaves, greenish yellow flowers and drupaceous fruits. In 
traditional medicine of Kerala, the roots of C. peltata are 
used against jaundice[4]. The Kurichiya tribe of Kerala use 
the tuberous roots of this plant along with a little salt to treat 
stomach pain[5]. The Garo tribe of Balphakram sanctuary in 
Meghalaya use the crushed root extract as a remedy against 
small pox[6]. We have already reported the antiulcer property 
of C. peltata[7]. However this therapeutic claim against liver 
disease has not been scientifically validated yet. Herein, 
we report the antioxidant and hepatoprotective properties 
of the roots of C. peltata against paracetamol (APAP)/carbon 
tetrachloride (CCl4)-induced liver damage in Wistar rats. 
   Pharmacological studies using C. peltata showed potent 
diuretic activity and in vitro anticancer activity, and also 
inhibits the stone formation induced by ethylene glycol 
treatment[8-10]. The post treatment of C. peltata extract might 
effectively ameliorate oxidative stress parameters observed in 
cisplatin-induced renal toxicity and could be used as natural 
antioxidant against cisplatin-induced oxidative stress[11]. 
   C. peltata roots are reported to contain alkaloids 
like fangchinoline, d-tetrandrine, dl-tetrandrine, 
d-isochondrodendrine, cycleapeltine, cycleadrine, 
cycleacurine, cycleanorine, etc[12,13]. Tetrandrine is well known 
to possess activities including antioxidant, plasma glucose 
lowering[14], anti-inflammatory, immunosuppressive, free 
radical scavenging[15], anti-fibrotic and anticancer properties. 
It is used clinically to treat hypertension and silicosis[16,17]. 
Fangchinoline is known to inhibit Ca2+ transmembrane 
movement and histamine release[18]. The Indian sample of root 
of C. peltata yielded tumor-inhibitory bisbenzylisoquinoline 
alkaloid tetrandrine as the major alkaloid[4,19].
2. Materials and methods
2.1. Plant material and preparation of the extract
   C. peltata roots were collected from Trivandrum district 
of Kerala, during August 2011 by Varghese Jancy Shine, 
Jawaharlal Nehru Tropical Botanic Garden and Research 
Institute (JNTBGRI) and authenticated by Dr. Mathew Dan, 
plant taxonomist of the Institute. A voucher specimen has 
been deposited at the JNTBGRI Herbarium (TBGT 13814 dated 
September 10, 2011). The roots were washed thoroughly 
in tap water, shade-dried and powdered. A total of 500 g 
plant material was extracted with methanol for 48 h using 
Soxhlet apparatus and dried under reduced pressure using 
rotoevaporator to yield 100 g methanol crude extract (MCP). 
Total alkaloid extract was isolated from MCP[20]. About 100 
g of MCP was dissolved in dilute H2SO4, filtered and pH was 
adjusted to 9.5. Free alkaloid was extracted with chloroform. 
The chloroform layer was filtered and concentrated under 
reduced pressure using rotoevaporator to yield 9 g alkaloid 
extract of C. peltata (ACP). It was suspended in 0.5% Tween-80 
to required concentrations and used for the experiments.
2.2. Animals
   Wistar albino rats, males (200-250 g) and Swiss albino mice, 
males (25-30 g), obtained from the JNTBGRI Animal House was 
used for the present study. They were housed under standard 
conditions and fed commercial rat feed (Lipton India Ltd, 
Mumbai, India) and boiled water ad libitum. All experiments 
involving animals were done according to NIH guidelines, 
after getting the approval of the Institute’s Animal Ethics 
Committee.
2.3. HPTLC estimation of tetrandrine content in ACP 
   TLC of the ACP was carried out using the solvent system 
toluene: ethyl acetate: diethylamine (7.2:2:0.8) modified 
method[7]. The chromatogram was visualized by spraying 
with Dragendroff’s reagent. Co-HPTLC of ACP and authentic 
tetrandrine (Sigma-Aldrich, USA) was also performed.
2.4. Direct analysis in real time-mass spectrometry (DART-
MS) of ACP 
   The mass spectrometer used was a JMS-T100 LC (Accu 
ToF) atmospheric pressure ionization time-of-flight mass 
spectrometer (Jeol, Tokyo, Japan) fitted with a DART ion source. 
The mass spectrometer was operated in positive-ion mode. 
The DART ion source was operated with helium gas flowing at 
4 L/min. The gas heater was set to 300 °C. The potential on the 
discharge needle electrode of the DART source was set to 3 000 
V. Orifice 1 potential was set at 28 V. The ACP was positioned 
in the gap between the DART source and mass spectrometer for 
measurements. Data acquisition was from m/z 10 to 1 050[21].   
2.5. APAP-induced liver damage
   APAP (Sigma Chemical Company, USA) was suspended in 
0.5% gum acacia and administered p.o., at a dose of 2.5 g/
kg. This dose is known to cause liver damage in rats[22]. Rats 
were divided into 6 groups (6 per group). Group I, the normal 
control group was given a single daily dose of 0.5% Tween-
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80, p.o., for 4 d. Group II, the APAP control group received 
a daily dose of  0.5% Tween-80 for 4 d and 2 mL of APAP 
suspension (2.5 g/kg, per os) on Day 3, 30 min after Tween-80 
administration. Groups III, IV and V received a daily dose of 
ACP 50, 100 and 150 mg/kg respectively p.o., for 4 d and 2 mL 
of APAP suspension (2.5 g/kg, p.o.) on Day 3, 30 min after ACP 
administration. Group VI animals received silymarin at a dose 
of 100 mg/kg p.o., on all the 4 d and 2 mL of APAP suspension 
(2.5 g/kg) p.o., 30 min after silymarin administration. 
2.6. CCl4-induced hepatotoxicity in rats
   Rats were divided into 6 groups (n=6). Group I (normal 
control) animals were administered a single daily dose of 
0.5% Tween-80, p.o., for 7 d and received olive oil (8 mL/
kg, i.p.) on Day 7. Group II (CCl4 control) received 0.5% 
Tween-80, p.o. once daily, for 7 d and received 0.2% CCl4 in 
olive oil (8 mL/kg, i.p.) on Day 7. Group III, IV and V were 
administered orally ACP 50, 100 and 150 mg/kg once daily for 
7 d respectively. Group VI received standard drug silymarin 
(100 mg/kg, p.o.) once daily for 7 d. Group III-VI animals 
were administered simultaneously 0.25 mL CCl4 in olive oil 
(8 mL/kg) on Day 7 after 1 h of administration of the ACP/
silymarin[23].
2.7. Assessment of liver function 
   On the 5th day of the APAP hepatotoxicity study and on the 
8th day of the CCl4 hepatotoxicity study, all the animals were 
sacrificed as per CPCSEA guidelines. Blood samples were 
collected for evaluating the serum biochemical parameters 
[glutamate pyruvate transaminase (SGPT), glutamate 
oxaloacetate transaminase (SGOT), alkaline phosphatase 
(SAKP), bilirubin and cholesterol] according to standard 
methods[24-27].  
2.8. Histopathological studies
   The liver samples from the above experiments were 
preserved in 10% buffered formalin and processed for 
routine paraffin block preparation. Using a rotary microtome 
(American Optical Co., USA), sections of thickness of 
about 5 µm were cut and stained with heamatoxylin and 
eosin. These were examined under the microscope for 
histopathological changes, such as necrosis, fatty changes, 
ballooning degeneration and infiltration of Kupffer cells and 
lymphocytes.
2.9. Liver tissue homogenate preparation
   The liver was washed thoroughly in ice-cold saline to 
remove the blood. It was then gently blotted between the 
folds of a filter paper and weighed in an analytical balance. 
Ten percentage of homogenate was prepared in 0.05 mol/
L phosphate buffer (pH 7) using a polytron homogenizer 
(Remi Motors, India, Pvt Ltd) at 20 °C. The homogenate was 
centrifuged at 6 000 r/min for 20 min to remove cell debris, 
unbroken cells, nuclei, erythrocytes and mitochondria. The 
supernatant was used for further hepatic biochemical assays.
2.10. Estimation of reduced glutathione (GSH) 
   To estimate GSH, 0.2 mL of tissue homogenate was 
mixed with 1.8 mL of ethylene diamine tetraacetic acid 
(EDTA) solution. To this 3 mL precipitating reagent (1.67 g 
of metaphosphoric acid, 0.2 g of EDTA disodium salt, 30 g 
sodium chloride in 1L of distilled water) was added and 
mixed thoroughly and kept for 5 min before centrifugation. To 
2 mL of the supernatant, 4 mL of 0.3 mol/L disodium hydrogen 
phosphate solution and 1 mL of DTNB (5,5-Dithio bis 2-nitro 
benzoic acid) reagent were added and absorbance was read 
at 412 nm. Absorbance values were compared with a standard 
curve generated from known GSH[28].
2.11. Estimation of superoxide oismutase (SOD) 
   Superoxide radicals react with nitroblue tetrazolium in the 
presence of NADH and produce formazan blue. SOD removes 
the superoxide radicals and inhibits the formation of formazan 
blue. The intensity of colour is inversely proportional to the 
activity of the enzyme. The reaction mixture contained 1.2 
mL sodium pyrophosphate buffer (pH 8.3, 0.025 mol/L), 0.1 
mL phenazine methosulphate (186 mmol/L), 0.3 mL nitroblue 
tetrazolium (NBT) (300 mmol/L), 0.2 mL NADH (780 mmol/L) and 
approximately diluted enzyme preparations and water in a 
total volume of 3 mL. After incubation at 30 °C for 90 seconds, 
the reaction was terminated by the addition of 1 mL glacial 
acetic acid. The reaction mixture was stirred vigorously 
and shaken with 4 mL n-butanol. The color intensity of the 
chromogen in the butanol layer was measured at 560 nm 
against n-butanol and concentration of SOD was expressed as 
units/mg protein. Absorbance values were compared with a 
standard curve generated from known SOD[29].
2.12. Estimation of catalase (CAT) activity 
   About 500 mg of the liver/stomach samples of the normal 
and drug treated groups were homogenized (Remi Motors, 
India, Pvt Ltd) with 10 mL 0.9% saline. The homogenate was 
used for determination of CAT activity. Decomposition of H2O2 
in presence of CAT was followed at 240 nm. One unit of CAT 
was defined as the amount of enzyme required to decompose 
1 mmol of H2O2 per min, at 25 °C and pH 7. Results were 
expressed as IU of CAT activity/g wet tissue[30].
2.13. Malondialdehyde (MDA) estimation
   The liver homogenate was suspended in thiobarbituric 
acid, and the optical density of the clear pink supernatant 
was read at 532 nm, after centrifugation. Malondialdehyde bis 
(dimethyl acetal) was used as standard[31]. 
2.14. Assesment of in vitro free radical scavenging property of 
ACP 
2.14.1. Hydroxyl radical scavenging activity of ACP 
   Hydroxyl radicals generated from Fe3+-ascorbate-EDTA- 
H2O2 were estimated by the degradation of deoxyribose 
that resulted in thiobarbituric acid reacting substances 
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formation. The reaction mixture contained deoxyribose (2.8 
mmol/L), FeCl3 (0.1 mmol/L), KH2PO4-KOH buffer (20 mmol/L, 
pH 7.4), EDTA (0.1 mmol/L), H2O2 (1 mmol/L), ascorbic acid (0.1 
mmol/L) and various concentrations of ACP, in a final volume 
of 1 mL. The reaction mixture was incubated at 37 °C for 1 h. 
Degradation of deoxyribose was measured by thiobarbituric 
acid method and percentage inhibition was calculated. 
Curcumin was used as reference compound[32].
2.14.2. Superoxide radical scavenging activity of ACP
   Superoxide radical scavenging activity of ACP was 
determined by NBT reduction method[33]. The reaction mixture 
contained EDTA (0.1 mol/L), 0.0015% NaCN, riboflavin (0.12 
mmol/L), NBT (1.5 mmol/L), and various concentrations of ACP 
and phosphate buffer (67 mmol/L, pH 7.8) in a total volume 
of 3 mL. The tubes were illuminated under an incandescent 
lamp for 15 min and thereafter the optical density was 
measured at 530 nm. The percentage inhibition of superoxide 
production was evaluated by comparing the absorbance 
of control and experimental tubes. Curcumin was used as 
reference compound.
2.14.3. DPPH radical scavenging activity of ACP
   DPPH radical scavenging activity was measured by the 
spectrophotometric method[34]. To a methanolic solution 
of DPPH (200 µmol/L), 0.05 mL of different concentrations 
of ACP was dissolved in ethanol and added at different 
concentrations (10-500 µg/mL). An equal amount of ethanol 
was added to the control. After 20 min, the decrease in the 
absorbance of test mixture (due to quenching of DPPH free 
radicals) was read at 517 nm, and the percentage inhibition 
was calculated by using the formula given below.
伊100Inhibition % = 
     (Control-test) 
Control
2.14.4. Anti-lipid peroxidation effects of ACP
   The anti-lipid peroxidant effect of ACP was studied as per 
standard method[23]. Protein content was determined by the 
method of Lowry et al[35]. Briefly, 2 g of rat liver tissue was 
sliced and homogenized with 150 mmol/L KCl-Tris-HCl buffer 
(pH 7.2). The reaction mixture was composed of 0.25 mL liver 
homogenate, Tris-HCl buffer (pH 7.2), 0.1 mmol/L ascorbic 
acid, 4 mmol/L FeCl2 and 0.005 mL of various concentrations 
of ACP. The mixture was incubated at 37 °C for 1 h in capped 
tubes. Then, 0.1 mol/L HCl, sodium dodecyl sulphate (9.8%), 
0.9 mL distilled water and 2 mL of thiobarbituric acid (0.6%) 
were added to each tube and vigorously shaken. The tubes 
were placed in a boiling water bath at 100 °C for 30 min. After 
cooling, 5 mL of butanol was added and centrifuged at 3 000 
r/min for 25 min. The absorbance of the supernatant was 
measured at 532 nm. The experiment was repeated twice. 
2.15. Behavioural and toxic effects 
   Five groups of 10 mice were administered p.o., 250, 500, 
750, 1 000 and 2 000 mg/kg of the ACP. They were observed 
continuously for 1 h for any gross behavioural changes, like 
drowsiness, restlessness, writhing, convulsion, piloerection, 
symptoms of toxicity and mortality if any, and intermittently 
for the next 6 h and then again, 24 h after dosing with ACP.
2.16. Statistical analysis 
   The results were expressed as mean依SD. Analysis of 
variance (ANOVA) was done to compare and analyse the 
data followed by Duncan’s multiple range test. Effects were 
considered significant at P≤0.01[36].
3. Results
3.1. HPTLC estimation of tetrandrine content in ACP
   HPTLC estimation of tetrandrine using different 
concentration of authentic tetrandrine and ACP has shown 
228.4 µg/mg ACP (Figure 1). 
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Figure 1. HPTLC estimation of tetrandrine. 
(a): Peak display of standard tetrandrine at 280 nm; (b): Peak display of at 280 
nm. 
3.2. DART-MS of alkaloid extract of ACP 
   DART analysis detected the presence of bisbenzyl 
isoquinoline alkaloids, tetrandrine (C38H42O8N2; MW 622.3), 
fangchinoline (C37H40N2O6; MW 608.288) and coclaurine 
(C17H19NO3; MW 285.33), which were detected as peaks of M+1 
values 623.365 72 (tetrandrine), 609.350 64 (fangchinoline) and 
286.148 81 (coclaurine) respectively (Figure 2). 
Figure 2. Representative DART-MS spectra of ACP. 
I: tetrandrine (C38H42O8N2; MW 622.30); II: fangchinoline (C37H40N2O6; MW 608.288); 
III: coclaurine (C17H19NO3; MW 285.33). 
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3.3. APAP/CCl4-induced hepatotoxicity in rats
   Both APAP and CCl4 produced severe liver damage as 
indicated by a marked increase in SGOT, SGPT, SAKP, 
bilirubin and cholesterol values of the toxin groups, in 
comparison with normal controls. Pretreatment with ACP 
(50, 100 and 150 mg/kg) caused significant reduction of 
these values in both the hepatotoxin treated cases, almost 
comparable to silymarin (100 mg/kg) treated groups (Tables 1 
and 2). Liver content of MDA, a marker of lipid peroxidation, 
increased and GSH, CAT, SOD were lowered after APAP/CCl4 
administration. ACP significantly decreased the liver MDA 
levels and increased the liver GSH, CAT, SOD levels in APAP/
CCl4 treated rats in a dose dependent manner. Silymarin (100 
mg/kg) pretreatment also showed significant antioxidant 
property via reduction in MDA and increase in GSH, CAT and 
SOD levels (Figures 3 and 4). 
3.4. Histopathological studies
   Histopathological studies also supported the biochemical 
studies. Control groups showed normal liver architecture with 
distinct hepatic cells, sinusoidal space and central vein. In 
the liver sections of rats intoxicated with APAP, degeneration 
of normal hepatic cells with intense centrilobular necrosis, 
broad infiltration of lymphocytes and Kupffer cells and loss 
of cell boundaries were observed. The liver sections of rats 
challenged with CCl4 showed necrosis, inflammation and 
Kupffer cell infiltration. However, administration of ACP/
silymarin to the groups intoxicated with APAP/CCl4 produced 
a marked degree of protection against the toxin-induced 
liver histological alterations (Figures 5 and 6).
Table 1
Effect of ACP on serum parameters in APAP-induced hepatic damage in Wistar rats.
Groups SGOT (IU/I) SGPT (IU/I) SAKP (KA Units) Cholesterol (mg/dL) bilirubin (mg/dL) 
Normal Control   36.50依4.25a  47.00依1.80a 70.40依2.16a 40.00依1.21b 0.24依0.02a 
APAP Control 113.66依2.40e 258.20依1.80e 120.00依1.17e 62.00依1.31d 0.97依0.03d
APAP+ACP (50 mg/kg)   67.33依2.56d  70.92依1.30d 85.00依2.20d 48.00依1.26c 0.37依0.02c 
APAP+ACP (100 mg/kg)   51.93依2.15c  60.92依2.10c 78.00依2.14c 40.00依1.50b 0.27依0.01b
APAP+ACP (150 mg/kg)   42.84依1.55b  49.88依2.20b 71.21依2.10b 37.01依1.12a 0.24依0.01a  
APAP+silymarin (100 mg/kg )   42.57依2.46b  50.22依2.10b 71.15依1.60b 36.00依2.12a 0.25依0.01a
Values are the mean依SD, n=6, ANOVA was followed by Duncan’s multiple range test. Means bearing same superscripts do not differ significantly 
(P≤0.01).
Table 2
Effect of ACP on serum parameters in CCl4-induced hepatic damage in Wistar rats.
Groups (units/mL) SGOT (IU/I) SGPT (IU/I) SAKP ((KA Units) Cholesterol (mg/dL) bilirubin (mg/dL) 
Normal Control  38.90依2.32a   48.90依2.11a 51.00依2.10a 43.00依3.00b 0.28依0.02a 
APAP Control 133.26依2.10e 278.20依1.89e 99.10依2.10d 70.00依1.65e 1.05依0.02d
APAP+ACP (50 mg/kg)   77.13依1.81d 120.92依2.10d 64.00依2.80c 53.00依1.90d 0.46依0.01c 
APAP+ACP (100 mg/kg)   58.160依2.310c   64.92依2.15c 58.00依2.91b 48.00依1.89c 0.40依0.02b
APAP+ACP (150 mg/kg)   42.28依1.62b   51.28依2.20b 50.00依2.12a  40.00依1.22a 0.28依0.02a  
APAP+silymarin (100 mg/kg  )   42.57依1.83b   51.82依2.10b 51.00依2.21a 40.00依2.32a 0.28依0.02a
Values are the mean依SD, n=6, ANOVA was followed by Duncan’s multiple range test. Means bearing same superscripts do not differ significantly 
(P≤0.01).
Figure 3. Effect of ACP on liver MDA, GSH, CAT and SOD levels in APAP treated rats. 
ACP 1=50 mg/kg, ACP 2=100 mg/kg and ACP 3=150 mg/kg. Values are the mean依SD, n=6, ANOVA was  followed by Duncan’s multiple range test, means bearing 
different superscripts differ significantly (P≤0.01). 
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3.5. Assesment of hydroxyl radical scavenging activity 
   Hydroxyl radical generated by Fe3+/ascorbate/EDTA/H2O2 
system initiated the degradation of deoxyribose which was 
inhibited significantly by ACP and its IC50 value is (38.00依2.68) 
µg/mL (Table 3).
3.6. Assesment of superoxide radical scavenging activity
   Percentage inhibition of superoxide radical generation 
by ACP was found to be increasing in a dose dependent 
manner, showing IC50 value of (41.00依1.23) µg/mL (Table 3).
Figure 4. Effect of ACP on liver MDA, GSH, CAT and SOD levels in carbon tetrachloride (CCl4) treated rats. 
ACP 1=50 mg/kg, ACP 2=100 mg/kg and ACP 3=150 mg/kg. Values are the mean依SD, n = 6, analysis of variance (ANOVA) followed by Duncan’s multiple range test, 
means bearing different superscripts differ significantly (P≤0.01). 
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Table 3
Effect of ACP on in vitro free radical (hydroxyl, superoxide and DPPH) 
scavenging effects.
Treatments Concentration  of 50% Inhibition of free radical (µg) 
Hydroxyl Superoxide DPPH
 ACP 38.00依2.68b 41.00依1.23b 31.00依1.53b
Curcumin   2.89依0.28a  5.89依0.45a  2.26依0.51a
Values are the mean依SD, n=6, analysis of variance (ANOVA) followed 
by Duncan’s multiple range test, means bearing different superscripts 
differ significantly (P≤0.01). 
Figure 5. Administration of ACP/silymarin to the groups intoxicated with 
APAP.
(a): Section of liver of normal control rats showing hepatic cells with well 
defined nuclei and cytoplasm (350伊). (b): Section of APAP treated rat liver 
showing marked necrosis, extensive vacuolation, broad infiltration of 
lymphocytes and Kupffer cells, loss of cell boundaries and disappearance 
of nuclei (350伊). (c): Section of APAP+ACP (150 mg/kg) treated rat liver 
showing marked improvement over APAP control group (350伊). (d): Section of 
APAP+silymarin (100 mg/kg) treated rat liver showing normalcy of hepatic cells 
(350伊). 
a b
c d
Figure 6. Administration of ACP/silymarin to the groups intoxicated with 
CCl4.
(a): Section of liver of normal control rat showing hepatic cell with well defined 
nuclei and cytoplasm (100伊). (b): Section of CCl4 treated rat liver showing 
moderate to marked necrosis, inflammatory changes (350伊). (c): Section of 
CCl4+ACP (150 mg/kg) treated rat liver showing improvement over CCl4 control 
group (350伊). (d): Section of CCl4+Silymarin (100 mg/kg) treated rat liver showing 
normalcy of hepatic cells (350伊).
a b
c d
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3.7. DPPH radical scavenging activity 
   The DPPH scavenging assay showed IC50 value for ACP as 
(31.00依1.53) µg/mL, standard curcumin having IC50 value of 
2.26 µg/mL (Table 3).
3.8. Assesment of anti-lipid peroxidation effects
   The ACP treatment showed significant reduction in the MDA 
levels in vitro dose dependently. The concentration needed 
for the 50% reduction of lipid peroxidation for ACP was (53.5依
1.21) µg/mL (Table 4).
Table 4
Inhibitory effect of ACP on FeCl2-ascorbic acid-induced lipid 
peroxidation in rat liver homogenate in vitro.
Treatments
ACP 
(µg/mL) 
MDA 
(nmol/g wet liver) 
MDA 
inhibition (%)
Normal control - 1.21依0.40c -
FeCl2-AA - 2.56依0.15
e -
FeCl2-AA+ACP 25 2.12依0.06
d
17.19a
FeCl2-AA+ACP 50 1.99依0.05
b
22.27b
FeCl2-AA+ACP 75 0.88依0.02
a
65.63c
FeCl2-AA+ACP      100 0.81依0.04
a
68.36c
Values are the mean依SD, n=3, analysis of variance (ANOVA) followed 
by Duncan’s multiple range test, means bearing different superscripts 
differ significantly (P≤0.01). AA: Ascorbic acid.
3.9. Behavioural and toxicity studies
   In the toxicity study, no mortality occurred within 24 h with 
the 5 doses of ACP tested. The LD50 was therefore greater than 
2 500 mg/kg p.o., in mice (Data not shown). 
4. Discussion
   Living in a world of inadequately controlled environmental 
pollution and expanding therapy with potent drugs, the 
liver, which is the key organ of metabolism and excretion 
is continually exposed to a variety of xenobiotics and 
therapeutic agents. Drug detoxification is a complex process 
that occurs in the endoplasmic reticulum of the hepatocytes 
which may cause oxidative damage through the production 
of reactive oxygen species. Therefore, it is valuable to 
identify natural drugs or compounds that can antagonize the 
deleterious action of free radicals and act as an antioxidant to 
protect hepatocytes from such damage.
   APAP is a potent analgesic, and antipyretic agent is 
metabolized in the liver. Toxic doses cause fatal liver 
damage. It is reported that one percentage of the casualty 
department attendance is due to APAP[37]. It is established 
that APAP is bioactivated to a toxic elecrophile, N-acetyl-
p-benzoquinoneimine, which binds covalently to tissue 
macromolecules and probably also oxidizes lipids or critical 
sulphydryl groups (protein thiols) and alters the homeostasis 
of calcium[38-40]. Carbon tetrachloride has long been 
used to produce experimental liver necrosis as a model 
hepatotoxicant and carcinogen. The mitochondria were 
found to be the component attacked by the poison, and the 
tricarboxylic acid cycle was disorganized. Mechanistic studies 
provided evidence that metabolism of carbon tetrachloride 
via CYP2E1 to highly reactive free radicals (trichloromethyl 
and trichloromethyl peroxy metabolite) plays a critical role 
in the postulated mode of action. The free radicals initiate 
lipid peroxidation by attacking polyunsaturated fatty acids 
in membranes, setting off a free radical chain reaction 
sequence. Lipid peroxidation is known to cause membrane 
disruption, resulting in the loss of membrane integrity 
and leakage of microsomal enzymes. By-products of lipid 
peroxidation include reactive aldehydes that can form protein 
and DNA adducts and may contribute to hepatotoxicity and 
carcinogenicity, respectively[41]. 
   Due to liver injury the transport function of the hepatocytes 
gets disturbed, resulting in the leakage of plasma 
membrane[42], thereby causing an increased enzyme level in 
the serum. In the present study, the hepatic damage produced 
by APAP/CCl4 is evident by increased marker enzymes (SGOT, 
SGPT, SAKP), bilirubin and cholesterol levels in the serum. In 
both toxicity, if the free radical generated is not inactivated 
by conjugation with GSH, it reacts with cell proteins and kills 
the cell[43]. Thus activation of antioxidant defense system by 
the ACP is the key step in hepatoprotection against APAP/CCl4 
hepatotoxicity. 
   GSH plays a pivotal role in mitochondrial antioxidant 
defense; its depletion increases the sensitivity of the hepatic 
tissue to free radical-mediated damage caused by xenobiotic 
metabolism[44,45]. In the present study, it was observed that 
ACP significantly inhibited the liver MDA levels and increases 
the liver GSH, CAT and SOD levels of APAP/CCl4 treated rats. 
This may be due to the inhibition of the deleterious effects of 
the free radicals formed during APAP/CCl4 metabolism by ACP. 
These findings support the significant antioxidant property of 
ACP and its free radical scavenging role in vivo. The in vitro 
free radical scavenging property of ACP also significantly 
supported the findings. Thus the observed hepatoprotective 
property of ACP was due to its free radical scavenging property 
via increasing endogenous antioxidant defense system. 
   A single dose of CCl4 led to a five-fold increase in liver 
calcium content. The calcium channel blockers showed a 
significant reduction in liver calcium content, decrease in 
AST and ALT levels, and a significant increase in protein 
synthesis and also a partial inhibition of lipid peroxidation[46]. 
Weakened cellular membranes allow sufficient leakage of 
calcium into the cytosol to disrupt intracellular calcium 
homeostasis, and high calcium levels in the cytosol 
activate calcium-dependent proteases and phospholipases 
that further increase the breakdown of the membranes. 
Similarly, the increase in intracellular calcium can activate 
endonucleases that can cause chromosomal damage and also 
contribute to cell death[41]. Lowering the calcium metabolism 
can reduce the pathological consequences of the attack by 
toxic metabolites[47]. 
   Tetrandrine and fangchinoline the major alkaloids present 
in C. peltata are reported to inhibit Ca2+ transmembrane 
movement[7,12,13,48]. Tetrandrine is well known to possess 
activities including antioxidant, anti-inflammatory, 
immunosuppressive, free radical scavenging, anti-
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fibrotic and anticancer properties. Coclaurine has a potent 
antispasmodic activity related to an inhibiting effect of 
extracellular calcium. Thus the synergistic action of alkaloids 
especially tetrandrine, fangchinoline and coclaurine may 
contribute to the hepatoprotective property of ACP. 
   The observed hepatoprotective property of ACP may be 
due to its antioxidant mechanism via scavenging the free 
radicals generated efficiently, anti-inflammatory through 
inhibition of reactive oxygen species and further inhibition of 
inflammatory cytokines and hepatocyte membrane stabilizing 
via inhibiting Ca2+ transmembrane movement. Therefore, it 
may be a promising agent in protecting hepatic tissue from 
liver injury and further studies are warranted to elucidate the 
mechanism of action. 
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Comments 
Background
   There are many hepatoprotective, antiulcer, antioxidants, 
gastro protective plants known from the wealth of traditional 
Ayurveda and folklore medicines, but their introduction 
into modern therapy awaits scientific validation. Scientific 
research in herbal medicine with hepatoprotective and 
antioxidant activity may be of great benefit as an alternative 
therapy for different liver diseases.
  
Research frontiers
   This paper describes the hepatoprotective property 
of alkaloid extract of C. peltata against CCl4 and APAP 
induced hepatic injury and assessed by estimating different 
biochemical paradigms and in vitro antioxidant parameters.
Related reports
   Both CCl4 and APAP are reported to cause hepatic necrosis 
due to formation of free radicals. The folklore medicine has 
evidence of effectiveness of herbs in treating various liver 
disorders.
Innovations and breakthroughs
   In traditional medicine of Kerala, the roots of C. peltata are 
used against jaundice. The Kurichiya tribe of Kerala uses 
the tuberous roots of this plant along with a little salt to treat 
stomach pain. The Garo tribe of Balphakram sanctuary in 
Meghalaya use the crushed root extract as a remedy against 
small pox. However this therapeutic claim against liver 
disease has not been scientifically validated yet. Herein, 
the authors report the antioxidant and hepatoprotective 
properties of the roots of C. peltata against APAP/CCl4-induced 
liver damage in Wistar rats. 
  
Applications
   C. peltata roots are reported to contain alkaloids 
like fangchinoline, d-tetrandrine, dl-tetrandrine,d-
isochondrodendrine,  cycleapelt ine,  cycleadrine, 
cycleacurine, cycleanorine, etc. Tetrandrine is well known 
to possess activities including antioxidant, plasma glucose 
lowering, anti-inflammatory, immunosuppressive, free radical 
scavenging, anti-fibrotic and anticancer properties. It is used 
clinically to treat hypertension and silicosis. Fangchinoline 
is known to inhibit Ca2+ transmembrane movement and 
histamine release. This scientific study support and suggest 
the use of this plant as an adjuvant along with commonly 
used hepatoprotective agent.    
Peer review
   The study carried out and presented in this paper is of high 
quality. The authors have demonstrated the hepatoprotective 
property of C. peltata in CCl4 and APAP induced liver 
toxicity in Wistar rats. The property was assessed based on 
biochemical parameters, antioxidant enzyme levels in liver 
homogenate and histopathological observations. C. peltata 
was found to be a promising hepatoprotective agent in CCl4 
and APAP rat models.
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